HR
AVEO

Howe & Rusling’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Howe & Rusling’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-35
Closed -$1K – 925
2018
Q4 		$1K Hold
35
– – ﹤0.01% 798
2018
Q3 		$1K Hold
35
– – ﹤0.01% 845
2018
Q2 		$1K Hold
35
– – ﹤0.01% 804
2018
Q1 		$1K Buy
+35
New +$1.02K ﹤0.01% 914

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Howe & Rusling's AVEO Position: Q1 2019 in Review

Howe & Rusling sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2019, closing a stake of 35 shares — an estimated $1K sold.

Howe & Rusling first reported a position in AVEO in Q1 2018 and held it in 4 quarters. The position peaked at $1K in Q4 2018. 83 funds tracked by Wall St. Rank hold AVEO as of Q1 2019.

  • Howe & Rusling reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2019 after selling out during the quarter.
  • Howe & Rusling sold 35 AVEO Pharmaceuticals, Inc. shares in Q1 2019, an estimated $1K.
  • Howe & Rusling first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 4 quarters.
  • Howe & Rusling's AVEO Pharmaceuticals, Inc. position peaked at $1K in Q4 2018.
  • 83 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2019.

Based on Howe & Rusling's 13F filing for Q1 2019, filed 29 Apr 2019.